Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based Biotherapeutics
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based Biotherapeutics
Authors
Keywords
Antigens, T cells, Immune response, Cytokines, Synthetic biotherapeutics, Glycation, Enzyme-linked immunoassays, Secretion
Journal
PLoS One
Volume 11, Issue 8, Pages e0159328
Publisher
Public Library of Science (PLoS)
Online
2016-08-06
DOI
10.1371/journal.pone.0159328
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunogenicity of Therapeutic Protein Aggregates
- (2016) Ehab M. Moussa et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Contribution of enhanced engagement of antigen presentation machinery to the clinical immunogenicity of a human interleukin (IL)-21 receptor-blocking therapeutic antibody
- (2015) L. Xue et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Physical Characterization and In Vitro Biological Impact of Highly Aggregated Antibodies Separated into Size-Enriched Populations by Fluorescence-Activated Cell Sorting
- (2015) Srivalli Telikepalli et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- The Immunogenicity of Antibody Aggregates in a Novel Transgenic Mouse Model
- (2015) Juliana Bessa et al. PHARMACEUTICAL RESEARCH
- Heterologous immunity between viruses
- (2015) Raymond M. Welsh et al. IMMUNOLOGICAL REVIEWS
- Detection of Innate Immune Response Modulating Impurities in Therapeutic Proteins
- (2015) Lydia Asrat Haile et al. PLoS One
- Impact of Glycation on Antibody Clearance
- (2014) Jane Yang et al. AAPS Journal
- Small Amounts of Sub-Visible Aggregates Enhance the Immunogenic Potential of Monoclonal Antibody Therapeutics
- (2014) Maryam Ahmadi et al. PHARMACEUTICAL RESEARCH
- Aggregation of Human Recombinant Monoclonal Antibodies Influences the Capacity of Dendritic Cells to Stimulate Adaptive T-Cell Responses In Vitro
- (2014) Verena Rombach-Riegraf et al. PLoS One
- T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation
- (2013) Vibha Jawa et al. CLINICAL IMMUNOLOGY
- Development of a Human Antibody Tolerant Mouse Model to Assess the Immunogenicity Risk Due to Aggregated Biotherapeutics
- (2013) Vivian Bi et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Stratification of Antibody-Positive Subjects by Antibody Level Reveals an Impact of Immunogenicity on Pharmacokinetics
- (2012) Lei Zhou et al. AAPS Journal
- Highly Aggregated Antibody Therapeutics Can Enhance thein VitroInnate and Late-stage T-cell Immune Responses
- (2012) Marisa K. Joubert et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Characterization and Quantitation of Aggregates and Particles in Interferon-β Products: Potential Links Between Product Quality Attributes and Immunogenicity
- (2012) James G. Barnard et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Use of human MonoMac6 cells for development of in vitro assay predictive of adjuvant safety in vivo
- (2012) Marina Zaitseva et al. VACCINE
- Rates and impact of human antibody glycation in vivo
- (2011) A. M. Goetze et al. GLYCOBIOLOGY
- Classification and Characterization of Therapeutic Antibody Aggregates
- (2011) Marisa K. Joubert et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chemical Modifications in Therapeutic Protein Aggregates Generated under Different Stress Conditions
- (2011) Quanzhou Luo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sustained suppression by Foxp3+regulatory T cells is vital for infectious transplantation tolerance
- (2011) Adrian R. Kendal et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immunogenicity of Recombinant Human Interferon Beta Interacting with Particles of Glass, Metal, and Polystyrene
- (2011) Miranda M.C. Van Beers et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Immunogenicity of Therapeutic Proteins: The Use of Animal Models
- (2011) Vera Brinks et al. PHARMACEUTICAL RESEARCH
- Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics
- (2010) Danika Wullner et al. CLINICAL IMMUNOLOGY
- Impact of Product-Related Factors on Immunogenicity of Biotherapeutics
- (2010) Satish Kumar Singh JOURNAL OF PHARMACEUTICAL SCIENCES
- Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product Development
- (2010) John den Engelsman et al. PHARMACEUTICAL RESEARCH
- Vesicular trafficking in immune cells
- (2009) Julia Kzhyshkowska et al. IMMUNOBIOLOGY
- Alternative activation of macrophages: Immune function and cellular biology
- (2009) Audrey Varin et al. IMMUNOBIOLOGY
- Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products
- (2008) Gopi Shankar et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product Quality
- (2008) John F. Carpenter et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach
- (2008) Peng Wang et al. PLoS Computational Biology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started